19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Contraindications Documented hypersensitivity; renal impairment<br />

Interactions<br />

NSAIDs may reduce hypotensive effects <strong>of</strong> captopril; ACE inhibitors<br />

may increase digoxin, lithium, and allopurinol levels; rifampin<br />

decreases captopril levels; probenecid may increase captopril levels;<br />

the hypotensive effects <strong>of</strong> ACE inhibitors may be enhanced when<br />

administered concurrently with diuretics<br />

Pregnancy D - Unsafe in pregnancy<br />

Precautions<br />

Drug Name<br />

Adult Dose<br />

Pediatric Dose<br />

Pregnancy category D in second and third trimester, pregnancy<br />

category C in first trimester; caution in renal impairment, valvular<br />

stenosis, or severe congestive heart failure<br />

Enalapril (Vasotec) -- Competitive inhibitor <strong>of</strong> ACE. Reduces<br />

angiotensin II levels, decreasing aldosterone secretion.<br />

1.25 mg (as enalaprilat)/dose IV over 5 min q6h; not to exceed 5<br />

mg/dose<br />

5-20 mg/d PO; not to exceed 40 mg/d<br />

IV: Not recommended (see precautions)<br />

PO: Not FDA approved for neonates; limited data exist, 0.08 mg/kg/d<br />

PO qd initially; may increase gradually, not to exceed 0.6 mg/kg/d<br />

Contraindications Documented hypersensitivity<br />

Interactions<br />

NSAIDs may reduce hypotensive effects <strong>of</strong> enalapril; ACE inhibitors<br />

may increase digoxin, lithium, and allopurinol levels; rifampin<br />

decreases enalapril levels; probenecid may increase enalapril levels;<br />

the hypotensive effects <strong>of</strong> ACE inhibitors may be enhanced when<br />

administered concurrently with diuretics<br />

Pregnancy D - Unsafe in pregnancy<br />

Precautions<br />

Pregnancy category D in second or third trimester, pregnancy<br />

category C in first trimester; the IV formulation is not recommended<br />

in managing neonatal hypertension due to risk <strong>of</strong> acute renal failure<br />

and oliguria; PO administration may be useful in the neonatal<br />

hypertension long-term management<br />

Drug Category: Diuretic agents -- Decrease plasma volume. Promote excretion <strong>of</strong> water and<br />

electrolytes by the kidneys. May be used as monotherapy or combination therapy to treat<br />

hypertension.<br />

Drug Name<br />

Chlorothiazide (Diuril) -- Inhibits reabsorption <strong>of</strong> sodium in distal<br />

tubules, causing increased excretion <strong>of</strong> sodium and water as well as<br />

potassium and hydrogen ions.<br />

Adult Dose 0.5-1 g PO divided qd/bid<br />

Pediatric Dose 5-15 mg/kg/dose PO bid<br />

Contraindications Documented hypersensitivity; anuria<br />

Interactions<br />

Thiazides may decrease effects <strong>of</strong> anticoagulants, antigout agents,<br />

and sulfonylureas; thiazides may increase toxicity <strong>of</strong> allopurinol,<br />

anesthetics, antineoplastics, calcium salts, loop diuretics, lithium,<br />

diazoxide, digitalis, amphotericin B, and nondepolarizing muscle<br />

relaxants<br />

Pregnancy D - Unsafe in pregnancy<br />

Precautions<br />

Caution in renal disease, hepatic disease, gout, diabetes mellitus,<br />

and erythematosus

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!